Becton, Dickinson (BDX) and laboratory automation company Biosero said Thursday they are collaborating to enable robotic arm integration with flow cytometry instruments used in drug discovery and development.
With robotic integration, steps in a lab's flow cytometry workflow that are now manual can become automated, substantially accelerating the process, the companies said.
Becton and Biosero said they will develop new capabilities within BD flow cytometer instrument software to be compatible with Biosero's Green Button Go software to facilitate robotic arm integration.
Financial terms of the collaboration were not disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.